Delivery Order SPE2DB24D2012-SPE2DB25FBXAD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,214.91 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was executed on September 22, 2025, with an ultimate completion date of September 23, 2025. The contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $19,211.98 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) under a firm fixed price contract. The award was made competitively with no set-aside designation on April 24, 2025, with completion expected by April 25, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $18,470.50 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $5,996.73 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract does not include a set-aside designation. Performance will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $19,044.34 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging). This competitively awarded, firm fixed-price contract was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order does not include a set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,920.02 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This contract, designated as a firm fixed price delivery order with no set-aside provisions, was competitively awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $2,612.81 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $17,527.44 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a firm fixed price structure. The order, issued on August 22, 2025, requires completion by August 25, 2025, and represents a competitive award with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,864.87 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on September 24, 2025, with completion targeted for September 25, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric/oncology pharmaceutical supply within the federal medical procurement system. The contract was fulfilled by AmerisourceBergen's Corporate Office division, with performance conducted at...
- The Defense Logistics Agency awarded a delivery order valued at $15,910.60 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed price contract type. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBXADDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,261.31 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) under a firm fixed price contract. This competitive award, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains an extensive portfolio of competitively awarded delivery orders covering a broad range of medications and medical supplies for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Ondansetron order fulfills routine pharmaceutical supply requirements for military medical operations without set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 9/23/25 |